55513-0132
Kanjinti
trastuzumab-anns
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
TRASTUZUMAB
420.0
mg/20mL
55513-0132-01
1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) > 20 mL in 1 VIAL, MULTI-DOSE
June 11, 2019
Immunotherapy
Monoclonal Antibody
HER2
 
In Use